BIOXYTRAN, INC

BIOXYTRAN, INC (ticker: BIXT) is an OTC-listed pharmaceutical preparations company. DredgeCap's structured extraction of BIXT's SEC filings surfaces 18 active risk signals, including 17 late-filing signals, and 1 auditor-change signal. BIXT reported $34K in revenue and -$2.12M for the period ending 2018-06-30, with operating cash flow of -$526K. Cash and equivalents stood at $510K (up 9793.6% year-over-year). Total assets of $659K are exceeded by total liabilities of $3.25M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.